Role of SCL/Tal-1, GATA, and Ets transcription factor binding sites for the regulation of Flk-1 expression during murine vascular development

Author:

Kappel Andreas1,Schlaeger Thorsten M.1,Flamme Ingo1,Orkin Stuart H.1,Risau Werner1,Breier Georg1

Affiliation:

1. From the Max-Planck-Institute for Physiological and Clinical Research, Bad Nauheim, Germany; the Center for Molecular Medicine, University of Köln, Köln, Germany; and the Howard Hughes Medical Institute, Harvard Medical School, Boston, MA.

Abstract

AbstractThe receptor tyrosine kinase Flk-1 is essential for embryonic blood vessel development and for tumor angiogenesis. To identify upstream transcriptional regulators of Flk-1, the gene regulatory elements that mediate endothelium-specific expression in mouse embryos were characterized. By mutational analysis, binding sites for SCL/Tal-1, GATA, and Ets transcription factors located in theFlk-1 enhancer were identified as critical elements for the endothelium-specific Flk-1 gene expression in transgenic mice. c-Ets1, a transcription factor that is coexpressed withFlk-1 during embryonic development and tumor angiogenesis, activated the Flk-1 promoter via 2 binding sites. One of these sites was required for Flk-1 promoter function in the embryonic vasculature. These results provide the first evidence that SCL/Tal-1, GATA, and Ets transcription factors act upstream ofFlk-1 in a combinatorial fashion to determine embryonic blood vessel formation and are key regulators not only of the hematopoietic program, but also of vascular development.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference57 articles.

1. Vasculogenesis.;Risau;Annu Rev Cell Dev Biol.,1995

2. Mechanisms of angiogenesis.;Risau;Nature.,1997

3. Failure of blood-island formation and vasculogenesis in flk-1-deficient mice.;Shalaby;Nature.,1995

4. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.;Millauer;Nature.,1994

5. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.;Millauer;Cancer Res.,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3